Leveille Chloe, Saad Mysa, Brabant Daniel, Birnie David, Fonseca Karina, Lee Elliott Kyung, Douglass Alan, Northoff Georg, Nikolitch Katerina, Carrier Julie, Fogel Stuart, Higginson Caitlin, Kendzerska Tetyana, Robillard Rebecca
School of Psychology, University of Ottawa, Canada; Sleep Research Unit, The University of Ottawa Institute of Mental Health Research at The Royal, Canada.
Sleep Research Unit, The University of Ottawa Institute of Mental Health Research at The Royal, Canada; Faculty of Medicine, Department of Medicine, University of Ottawa, Canada.
J Psychosom Res. 2025 Feb;189:111996. doi: 10.1016/j.jpsychores.2024.111996. Epub 2024 Nov 29.
Autonomic nervous system dysfunction and reduced heart rate variability (HRV) often co-exist with mood disorders, a phenomenon likely influenced by sleep disturbances. This study investigated heart rate (HR) and HRV across wake, rapid eye movement (REM) sleep, and non-REM (NREM) sleep in individuals with sleep complaints and bipolar or unipolar depressive disorder.
Polysomnographic data was retrospectively collated for 120 adult patients with sleep complaints and depressive symptoms [60 diagnosed with bipolar disorder, 60 diagnosed with a unipolar depressive disorder], and 60 healthy controls. HR and time-based HRV variables were computed on 30-s segments and averaged across the night for wake, NREM and REM sleep.
Significant group by consciousness state interactions showed that the unipolar and bipolar groups had lower standard deviation of normal-to-normal intervals root mean square of successive R-R interval differences compared to controls during NREM and REM sleep, but not during wake (SDNN: F(4, 330) = 3.0, p = .021, np2 = 0.035; RMSSD: F(4, 332) = 5.8, p < .001, np2 = 0.065). The magnitude of these group differences did not vary significantly between NREM 1, NREM 2 and NREM 3 sleep. These interactions persisted after excluding individuals taking 3rd generation antipsychotic, lithium, anticonvulsant, and cardiovascular medications.
Although further work is required to account for the impact of psychotropic and cardiac medications, as well as manic and euthymic states, these findings suggest that the sleep-based autonomic signature of depressive states differs across different types of mood disorders and could potentially inform the development of biomarkers and therapeutic targets.
自主神经系统功能障碍和心率变异性(HRV)降低常与情绪障碍并存,这一现象可能受睡眠障碍影响。本研究调查了有睡眠主诉以及双相或单相抑郁症患者在清醒、快速眼动(REM)睡眠和非快速眼动(NREM)睡眠期间的心率(HR)和HRV。
回顾性整理了120例有睡眠主诉和抑郁症状的成年患者[60例诊断为双相情感障碍,60例诊断为单相抑郁症]以及60例健康对照者的多导睡眠图数据。HR和基于时间的HRV变量在30秒时间段内计算,并在夜间对清醒、NREM和REM睡眠进行平均。
显著的意识状态组间交互作用表明,单相和双相情感障碍组在NREM和REM睡眠期间与对照组相比,正常到正常间期的标准差、连续R-R间期差异的均方根较低,但在清醒时无差异(SDNN:F(4, 330) = 3.0,p = .021,ηp2 = 0.035;RMSSD:F(4, 332) = 5.8,p < .001,ηp2 = 0.065)。这些组间差异的幅度在NREM 1、NREM 2和NREM 3睡眠期间无显著变化。在排除服用第三代抗精神病药物、锂盐、抗惊厥药物和心血管药物的个体后,这些交互作用仍然存在。
尽管需要进一步研究以解释精神药物和心脏药物的影响,以及躁狂和心境正常状态的影响,但这些发现表明,抑郁状态基于睡眠的自主神经特征在不同类型的情绪障碍中有所不同,并可能为生物标志物和治疗靶点的开发提供信息。